<DOC>
	<DOCNO>NCT02318758</DOCNO>
	<brief_summary>A study assess interaction acohol oral treprostinil .</brief_summary>
	<brief_title>Pharmacokinetic Interaction Oral Treprostinil Ethanol Healthy Volunteers</brief_title>
	<detailed_description>This study compare effect ethanol PKs 1 mg dose UT-15C healthy volunteer determine vivo effect ethanol , include time ethanol consumption relation UT-15C ingestion . This open-label , randomize , single-center , four-way ( period ) , crossover study 28 healthy volunteer receive single 1 mg oral dose UT-15C and/or ethanol . Eligible subject randomly assign one four treatment sequence subject receive four sequence pre-specified order .</detailed_description>
	<mesh_term>Treprostinil</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>1 . The subject voluntarily give informed consent participate study . 2 . Women child bear potential include female experience menarche undergone successful surgical sterilization . Women childbearing potential must practice true abstinence intercourse line prefer usual lifestyle , use two different form highly effective contraception duration study , least 30 day discontinue study medication . Medically acceptable form effective contraception include : ( 1 ) approve hormonal contraceptive ( birth control pill ) , ( 2 ) barrier method use spermicide , ( 3 ) intrauterine device , ( 4 ) partner vasectomy . For woman childbearing potential , negative urine pregnancy test require Screening Baseline prior initiate study medication . 3 . The subject , male , must use condom length study , least 48 hour discontinue study medication . 4 . Healthy male female subject age 2155 year age time sign informed consent . 5 . Weight 55 100 kg , BMI 19.029.9 kg/m2 , inclusive female subject weight 55 120 kg , BMI 19.032.0 kg/m2 , inclusive male subject . 6 . Regular consumption ethanol recent change pattern consumption 7 . In opinion Principal Investigator , subject able communicate effectively study personnel , consider reliable , willing likely cooperative protocol requirement , include attend study visit . 1 . The subject pregnant lactating . 2 . Subject clinically relevant abnormality identify screen physical examination , 12lead ECG , laboratory examination . 3 . Subject history anaphylaxis , previous document hypersensitivity reaction , clinically significant idiosyncratic reaction drug . 4 . Subject clinically significant history neurological , cardiovascular , respiratory , endocrine , hematological , hepatic , renal , gastrointestinal , genitourinary , pulmonary , and/or musculoskeletal disease ; glaucoma ; psychiatric disorder , chronic disease , whether control medication . 5 . Subject history postural hypotension , unexplained syncope . 6 . Subject blood pressure le 85 mmHg systolic 50 mmHg diastolic Screening Baseline . 7 . Subject pulse rate great 90 bpm sit rest 5 minute Screening Baseline . 8 . Subject blood pressure great 150 mmHg systolic 90 mmHg diastolic Screening Baseline . 9 . Subject predispose condition could interfere absorption , distribution , metabolism , excretion drug . 10 . Subject test positive screen visit HIV infection , HBsAg , HCV antibody . 11 . Subject currently use tobacco product history tobacco use within two month prior Baseline . 12 . Subject history ethanol abuse history current impairment organ function reasonably related ethanol abuse . 13 . Subject history current evidence abuse licit illicit drug , include positive urine screen drug abuse Screening Baseline . 14 . Subject history abnormal bleeding tendency . 15 . Subject donate blood plasma lose significant volume blood within four week prior Baseline . 16 . Subject clinically significant abnormal laboratory value opinion treat Investigator . 17 . Subject participate research study within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>This healthy volunteer study .</keyword>
</DOC>